Evidence map›Paper›PMID 39204361›Full record

ArticlePharmaceutics2024

Synthesis of Gelatin Methacryloyl Analogs and Their Use in the Fabrication of pH-Responsive Microspheres.

Karolina Valente, Geneviève N Boice, Cameron Polglase, Roman G Belli, Elaina Bourque, Afzal Suleman, Alexandre Brolo

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karolina ValenteVoxCell BioInnovation Inc., Victoria, BC V8T 5L2, Canada.
Geneviève N BoiceVoxCell BioInnovation Inc., Victoria, BC V8T 5L2, Canada.
Cameron PolglaseVoxCell BioInnovation Inc., Victoria, BC V8T 5L2, Canada.
Roman G BelliDepartment of Chemistry, University of Victoria, Victoria, BC V8P 5C2, Canada.
Elaina BourqueDepartment of Chemistry, University of Victoria, Victoria, BC V8P 5C2, Canada.
Afzal SulemanDepartment of Mechanical Engineering, University of Victoria, Victoria, BC V8P 5C2, Canada.
Alexandre BroloDepartment of Chemistry, University of Victoria, Victoria, BC V8P 5C2, Canada.ORCID 0000-0002-3162-0881

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

pH-responsive hydrogels have numerous applications in tissue engineering, drug delivery systems, and diagnostics. Gelatin methacryloyl (GelMA) is a biocompatible, semi-synthetic polymer prepared from gelatin. When combined with aqueous solvents, GelMA forms hydrogels that have extensive applications in biomedical engineering. GelMA can be produced with different degrees of methacryloyl substitution; however, the synthesis of this polymer has not been tuned towards producing selectively modified materials for single-component pH-responsive hydrogels. In this work, we have explored two different synthetic routes targeting different gelatin functional groups (amine, hydroxyl, and/or carboxyl) to produce two GelMA analogs: gelatin A methacryloyl glycerylester (polymer A) and gelatin B methacrylamide (polymer B). Polymers A and B were used to fabricate pH-responsive hydrogel microspheres in a flow-focusing microfluidic device. At neutral pH, polymer A and B microspheres displayed an average diameter of ~40 µm. At pH 6, microspheres from polymer A showed a swelling ratio of 159.1 ± 11.5%, while at pH 10, a 288.6 ± 11.6% swelling ratio was recorded for polymer B particles.

Indexed as

drug delivery systemsflow-focusing microfluidic devicegelatin methacryloylhydrogel microspherespH-responsive hydrogel

Identifiers

PMID39204361
PMCPMC11360800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.